Policy2 sources
White House Yanks Pick for FDA Chief
The Brief · written from 2 sources
- The White House withdrew its nomination of Heidi Overton, MD, PhD, to lead the FDA on November 17, 2026.
- The withdrawal came as indications grew that Overton lacked the votes needed for Senate confirmation.
- The Senate health committee had been scheduled to vote on her nomination on Wednesday morning.
Why it matters
The FDA is without a nominee for commissioner, so the agency's leadership and direction remain unsettled. Science and medical readers should watch who is nominated next and how the Senate responds.
Who’s affected
- readers following FDA leadership and US health policy
- physicians and researchers who depend on FDA regulatory decisions
- #fda
- #fda commissioner
- #senate confirmation
- #white house
- #health policy
(MedPage Today) -- The White House said Tuesday it has pulled the nomination of Heidi Overton, MD, PhD, to lead the FDA amid growing indications she didn't have the votes needed to win Senate confirmation. Overton, a physician and White House...